Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Overview
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Companies Involved in Therapeutics Development
AbbVie Inc
Amgen Inc
Cielo Therapeutics Inc
Nemucore Medical Innovations Inc
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Drug Profiles
AMG-900 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCT-137690 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
danusertib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ilorasertib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NMI-900 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Dormant Products
Aurora Kise C (Aurora 3 or Aurora/IPL1 Related Kise 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kise 13 or Serine/Threonine Protein Kise Aurora C or AURKC or EC 2.7.11.1) - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Top 10 Indications, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019


List of Tables


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indication, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by AbbVie Inc, H2 2019
Pipeline by Amgen Inc, H2 2019
Pipeline by Cielo Therapeutics Inc, H2 2019
Pipeline by Nemucore Medical Innovations Inc, H2 2019
Dormant Products, H2 2019
Dormant Products, H2 2019 (Contd..1), H2 2019
Dormant Products, H2 2019 (Contd..2), H2 2019
Discontinued Products, H2 2019